Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Brand Name :
N/A
Synonyms :
medical cannabis
Class :
Cannabinoid
Dosage Forms & Strengths
Sprays
1 drop/dose
Put 1 drop via sublingual route daily
Dosing modification
Renal Impairment
Drug modification not required
Hepatic Impairment
Drug modification not required
Not suggested
Refer to adult dosing
cannabis: they may increase the CNS depressant effect of amino alcohol
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
Actions and Spectrum
The primary active compounds in medical cannabis are cannabinoids, which interact with the body’s endocannabinoid system to produce various effects.
The two most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). Type 1 (CB1) and type 2 (CB2) cannabinoid receptors may be directly or indirectly activated by THC and CBD when they interact with the endocannabinoid system.
Frequency not defined
Circulatory shock
Deep vein thrombosis
Dehydration, hot flash
Acute myocardial infarction
Atrial fibrillation
Cerebrovascular accident
Cellulitis, hyperhidrosis
Pressure ulcer, pruritus
Increased thirst
Abdominal pain, constipation
Increased appetite, nausea, oral mucosa ulcer
Bladder dysfunction
Urinary tract infection
Decreased gastrointestinal motility, diarrhea
Dysgeusia, dysphagia, gastroenteritis
Anemia, leukopenia
Hepatic fibrosis, liver steatosis
Hypersensitivity reaction
Infection, sepsis
Lymphadenopathy
Abnormal hepatic function tests
Abnormal dreams, aggressive behavior
Agitation, amnesia
Confusion, decreased mental acuity, delusion
Lack of concentration, memory impairment
Anxiety, apathy, ataxia
Balance impairment, bipolar mood disorder
Mood changes
Mouth pain, myasthenia
Cough, dyspnea
Lower respiratory tract infection
Psychosis, schizophrenia
Sedated state, seizure, speech disturbance
Asthenia, muscle spasm, muscle twitching
Nervousness, panic attack
Paranoid ideation, Paresthesia
Myalgia, osteomyelitis, tremor
Blurred vision, eye redness
Tinnitus
Acute pulmonary reaction (bronchodilation)
Drug tolerance, fever
Black Box Warning
None
Contraindication/Caution:
Contraindication:
Caution:
Pregnancy consideration:
Pregnancy category: N/A
Lactation: some metabolites of drug may present in human milk
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
tetrahydrocannabinol (THC), the psychoactive component of cannabis, binds to cannabinoid receptor type 1 (CB1) receptors, particularly in the brain. By activating CB1 receptors, THC can produce various effects, including altered perception, mood changes, and euphoria.
Pharmacodynamics
cannabidiol (CBD) has a low affinity for CB1 and CB2 receptors and does not produce psychoactive effects. CBD modulates the activity of CB1 receptors indirectly.
Pharmacokinetics
Absorption
The absorption of medical cannabis depends on the route of administration. When cannabis is inhaled, the cannabinoids are rapidly absorbed through the lungs into the bloodstream.
Distribution
medical cannabis is distributed throughout the body.
Metabolism
medical cannabis is primarily metabolized in the liver. The main metabolic pathway for THC is through the liver enzyme cytochrome P450 (CYP450) system.
Elimination and excretion
medical cannabis is excreted from the body primarily through urine and feces.
Administration
medical cannabis can be administered through various routes like Inhalation in form of smoking; Oral; Sublingual in form of tincture and Topical in form of cream and lotion.
Patient information leaflet
Generic Name: medical cannabis
Why do we use medical cannabis?
medical cannabis has shown promise in managing chronic pain conditions, such as neuropathic pain, arthritis and fibromyalgia.
medical cannabis may help some individuals with insomnia or sleep disturbances.
medical cannabis also used to reduce muscle spasms and spasticity.